Transformers and Rectifiers (India) Limited — Q2 & H1 FY27 Earnings Call (held Oct 13, 2026)
1. Overall Tone of Management: Optimistic
- Management highlights “better execution, improved capacity utilization, and operating leverage” and reports strong profitability improvement.
- Strong forward-looking confidence: “remain confident of achieving FY27 guidance” and “on track with our growth plans.”
- Emphasis on expanding order visibility: unexecuted order book up 32% YoY to ₹7,237 crore and order inflows +97% YoY.
2. Key Themes from Management Commentary
- Execution & operating leverage improving
- Q2 standalone revenue ₹709 crore (+66% YoY); EBITDA margin 16.1% (vs 8.8% YoY).
- Attribution: capacity utilization + execution + operating leverage.
- Order book strength / revenue visibility
- Unexecuted order book ₹7,237 crore, executable in 18–24 months.
- Order inflows ₹1,169 crore in Q2 (+97% YoY).
- Negotiation pipeline: ₹21,000 crore inquiries under negotiation.
- Strategic wins & market breadth
- Entry into nuclear power sector (NPCIL Kaiga generator transformers).
- Large orders across utilities/industrial: Megha Engineering, APTRANSCO LOI, DVC, GETCO reactors & auto-transformers.
- Capacity expansion & backward integration
- Changodar expansion near completion, commercial production expected around Diwali.
- Backward integration progressing as per timeline.
- UK subsidiary formed to strengthen customer support and Europe presence.
- Demand environment supportive
- Mentions multi-year capex across transmission, renewables integration, grid modernization, plus data centers, rail electrification, EV infrastructure.
- Working capital focus
- Management targets reducing working capital cycle to improve cash flow (details in Q&A).
3. Q&A Analysis
Theme A: Order specifics (Kaiga / Megha) & competitive positioning
- Core questions
- What exactly are the Kaiga and Megha orders (size, ratings, who competed)?
- Does new competitor Kanohar overlap in segments?
- What portion of order book is 400 kV+?
- Management response
- Kaiga: competed with Crompton and other large manufacturers; generator transformers for nuclear; repetitive; rating 400 kV+.
- Kanohar: competition in 132 kV and 220 kV segments.
- 400 kV+ mix: ~55–60% of order book is 400 kV and above.
- Execution mix in Q2: ~56% of power transformer executed in the quarter is high-voltage (as discussed).
- Assessment
- Direct answers on competition and mix; no obvious evasion.
Theme B: Cash flow / working capital targets
- Core questions
- When will positive free cash flow start?
- What is the working capital cycle day target?
- Management response
- Positive cash flow expected after end of FY27 as working capital cycle reduces.
- Target: 120–130 days, with intent to go below 120 days and then 110–120 days “this year.”
- Assessment
- Clear targets, but still framed as “will”/“trying,” not guaranteed.
Theme C: Raw material / price risk & margin protection
- Core questions
- Are raw material prices still elevated (transformer oil, CRGO)?
- Any margin impact from earlier inventory purchases?
- How much price rise passed to customers?
- Management response
- Raw material prices still higher, but price variation clauses protect margins.
- Inventory bought due to disruptions: no margin impact expected because backward integration should be functional by FY28–FY29.
- Price variation: no one-time price rise; price variation billed every quarter.
- Revenue attribution: ~7–8% of revenue growth from price variation.
- Assessment
- Strong “protection” narrative; relies heavily on contractual clauses and backward integration timing.
Theme D: Capacity expansion details, capex, and margin uplift
- Core questions
- Changodar expansion capacity and capex; total capacity impact.
- Backward integration completion timing and expected margin expansion.
- Capacity utilization targets (including FY28).
- Management response
- Changodar: capacity to 35,000 MVA; capex ~₹150 crore; total capacity to ~75,000 MVA.
- Realization: ~₹7 lakhs per MVA average.
- Backward integration: expected completion by Q1 FY28; margin expansion +200 to +300 bps.
- Capacity utilization: target ~90% ideally; working toward it.
- Assessment
- Quantitative and consistent; however, utilization confidence is still somewhat conditional (“ideally,” “working towards”).
Theme E: Guidance credibility / growth math (FY27, USD 1B, spillover)
- Core questions
- Is FY27 growth guidance conservative given order book and Diwali ramp?
- Confirm USD 1B revenue guidance timeline and whether additional funding/capex is needed.
- Management response
- FY27 revenue growth target maintained at ~25%; explanation: need to execute ~₹900+ crore per quarter in H2.
- USD 1B: late FY29 or early 2030.
- Funding: no additional capex / no additional funding required; capacity expansion and backward integration already planned.
- Assessment
- Management defended conservatism with execution math; USD 1B timeline reiterated but not fully reconciled with earlier “FY28–FY29” messaging (see historical section).
Theme F: HVDC strategy and approvals
- Core questions
- Progress on HVDC repair order and when HVDC manufacturing revenues start.
- Strategy vs MNCs (LCC/VSC/hybrid) and ability to qualify.
- Management response
- Repair timeline: repair + commissioning + qualification implies ~1 to 1.5 years from the call.
- HVDC manufacturing: indigenously made HVDC; within next 18 months they expect to be able to do HVDC and converter transformers.
- Strategy: “hybrid” approach; avoid discussing further details.
- Assessment
- Reasonable timeline; still dependent on approvals/qualification.
Theme G: BESS transformers & CTC backward integration status
- Core questions
- Are they executing BESS transformers now? Pipeline size?
- CTC plant commissioning timing; any delay vs prior guidance.
- Management response
- BESS: not currently executing, but expect orders in the quarter; market assessed as “new.”
- CTC: commissioned by Q3; before Diwali; trial runs in Nov–Dec; commercial manufacturing by quarter four; ~60% captive.
- On “delay” claim: management says not delayed; it’s Q3 now.
- Assessment
- Some defensiveness on “delay” framing; still provides a clear revised schedule.
4. Guidance / Outlook
Explicit guidance (quantitative)
- FY27 revenue growth: ~25% (reaffirmed in Q&A).
- FY27 EBITDA margin: ~16% (16%–odd) (reaffirmed).
- FY27 PAT margin: ~9% to 10% (reaffirmed).
- Working capital cycle target: 120–130 days, intent to go below 120 days and then 110–120 days.
- Changodar capex: ~₹150 crore.
- Backward integration margin uplift: +200 to +300 bps.
- Capacity utilization: ~90% ideally (working toward).
Implicit signals (qualitative)
- Execution confidence tied to Diwali ramp and order book executable window.
- Margin protection continues to rely on price variation clauses and backward integration coming online by FY28.
- No additional funding/capex expected beyond planned expansion (management states funding is already planned).
5. Standout Statements (direct / revealing)
- Order visibility & growth
- “unexecuted order book stood at 7,237 crore, up by 32% year-on-year… executable over the next 18 to 24 months.”
- Capacity ramp timing
- “commercial production expected to commence around Diwali.”
- Cash flow
- “targeting end of this financial year to start reducing our working capital cycle days… that will give us a positive cash flows.”
- Margin protection mechanism
- “majority of order… having a price variation clause… does not affect our margin in a big way.”
- USD 1B timeline
- “late part of FY29 or early 2030.”
- Funding stance
- “No additional capex… no additional capex… already doing this capacity expansion, backward integration… is already well planned.”
- CTC schedule defense
- “We are not delaying… Q3… before Diwali the plant will be commissioned.”
6. Red Flags / Positive Signals
Positive signals
– Strong profitability improvement: EBITDA margin 16.1% in Q2 vs 8.8% YoY.
– Clear operational milestones (Diwali Changodar ramp; backward integration by Q1 FY28).
– Order book growth and high-voltage mix (~55–60% 400 kV+).
– Working capital targets explicitly quantified.
Red flags
– Timeline consistency risk: CTC commissioning narrative includes “not delayed” but analysts challenged prior guidance; still a potential credibility issue.
– USD 1B timeline drift: current call says late FY29/early 2030, while earlier calls referenced FY28–FY29 (see below).
– Reliance on price variation clauses and backward integration timing for margin protection—if either slips, downside risk exists.
– Some answers are conditional (“ideally,” “working towards”), especially on utilization and cash flow timing.
7. Historical Comparison & Consistency Analysis (vs prior 3 calls provided)
a. Change in Tone Over Time
- Q1 FY27 (Jul 21, 2026): More cautious/transition-focused due to Changodar expansion teething issues; still confident but acknowledged sequential pressure.
- Q2 & H1 FY27 (current): More optimistic—management attributes performance to execution improvement and reports strong margins and order inflows.
- Shift classification: More Optimistic.
- What changed:
- Stronger language on execution: from “transitional/teething issues” to “better execution, improved capacity utilization.”
- More willingness to provide operational targets (working capital cycle, utilization, capex, margin uplift).
b. Tracking Past Commitments vs Outcomes
1) Changodar expansion completion / ramp
– Past statement (Q1 FY27, Jul 21, 2026): Expansion issues; stabilization expected from Q3 FY27 onwards.
– Current (Q2 FY27): “commercial production expected to commence around Diwali.”
– Assessment: ✅ On track / progressing (no explicit miss; timing now tied to Diwali).
2) CTC commissioning timing
– Past statement (Q1 FY27, Jul 21, 2026): CTC facility targeted commissioning by Q2 FY27.
– Current (Q2 FY27): CTC commissioned by Q3; “before Diwali,” commercial manufacturing by quarter four.
– Assessment: ⏳ Delayed (Q2 → Q3; management disputes “delay,” but the calendar shift is acknowledged by the Q&A).
3) USD 1B revenue target timeline
– Past statement (Q1 FY27, Jul 21, 2026): “constantly working on 1 billion by FY’28, FY’29.”
– Current: “late part of FY29 or early 2030.”
– Assessment: ⏳ Pushed out (or at least broadened to early 2030).
4) Working capital improvement / cash flow
– Past statement (Q1 FY27, Jul 21, 2026): Target working capital cycle reduction; “targeting 120–130 days” appears in earlier calls too.
– Current: reiterates 120–130 days and intent to go below 120 and 110–120.
– Assessment: ✅ Consistent (no clear miss; still a target).
c. Narrative Shifts
- From “capacity teething issues” to “execution-led margin expansion.”
- Backward integration emphasis remains, but now tied more directly to margin expansion (+200–300 bps) and cash flow improvement.
- HVDC narrative continues, but now with more concrete “next 18 months” capability framing.
d. Consistency & Credibility Signals
- Medium credibility overall:
- Strong operational execution narrative in Q2 (supported by reported margins and revenue growth).
- However, CTC timing and USD 1B timeline show slippage/adjustment vs earlier messaging.
- Management sometimes responds to “delay” accusations with “not delayed,” but the revised schedule is still later than the earlier Q2 target.
e. Evolution of Key Themes
- Demand: Stable to improving (more order wins and supportive macro narrative).
- Margins: Improving sharply in Q2; management continues to guide margin expansion via backward integration.
- Capacity expansion: Now moving from “delays/monsoon” to “Diwali ramp” and “Q1 FY28 backward integration completion.”
- Cash flow: Increasing focus; explicit working capital cycle targets now central to outlook.
f. Additional Insights (cross-period intelligence)
- The company’s margin story increasingly depends on two levers:
1) Utilization ramp (Changodar/Moraiya execution)
2) Backward integration timing - The cash flow narrative is being used to validate the margin story—if working capital reduction slips, free cash flow timing could become a recurring concern.
- The order book is consistently strong, but management continues to emphasize selectivity and execution window limits—suggesting they are managing risk of margin dilution and working capital strain.